• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Comparison of mortality and outcomes of four respiratory viruses in the intensive care unit: a multicenter retrospective study

tetano

Editor, Senior Moderator
Sci Rep


. 2024 Mar 20;14(1):6690.
doi: 10.1038/s41598-024-55378-x. Comparison of mortality and outcomes of four respiratory viruses in the intensive care unit: a multicenter retrospective study

Baptiste Grangier[SUP] 1 [/SUP], Charles-Hervé Vacheron[SUP] 1 2 [/SUP], Donatien De Marignan[SUP] 1 [/SUP], Jean-Sebastien Casalegno[SUP] 3 4 [/SUP], Sandrine Couray-Targe[SUP] 5 [/SUP], Audrey Bestion[SUP] 5 [/SUP], Florence Ader[SUP] 6 7 [/SUP], Jean-Christophe Richard[SUP] 8 9 [/SUP], Emilie Frobert[SUP] 3 4 [/SUP], Laurent Argaud[SUP] 10 [/SUP], Thomas Rimmele[SUP] 11 [/SUP], Anne-Claire Lukaszewicz[SUP] 11 [/SUP], Frédéric Aubrun[SUP] 12 [/SUP], Frédéric Dailler[SUP] 13 [/SUP], Jean-Luc Fellahi[SUP] 14 [/SUP], Julien Bohe[SUP] 1 [/SUP], Vincent Piriou[SUP] 1 15 [/SUP], Bernard Allaouchiche[SUP] 1 16 [/SUP], Arnaud Friggeri[SUP] 1 4 [/SUP], Florent Wallet[SUP] 17 18 [/SUP]; Lyon Sud COVID-19 ICU



Collaborators, Affiliations
Free article Abstract

This retrospective study aimed to compare the mortality and burden of respiratory syncytial virus (RSV group), SARS-CoV-2 (COVID-19 group), non-H1N1 (Seasonal influenza group) and H1N1 influenza (H1N1 group) in adult patients admitted to intensive care unit (ICU) with respiratory failure. A total of 807 patients were included. Mortality was compared between the four following groups: RSV, COVID-19, seasonal influenza, and H1N1 groups. Patients in the RSV group had significantly more comorbidities than the other patients. At admission, patients in the COVID-19 group were significantly less severe than the others according to the simplified acute physiology score-2 (SAPS-II) and sepsis-related organ failure assessment (SOFA) scores. Using competing risk regression, COVID-19 (sHR = 1.61; 95% CI 1.10; 2.36) and H1N1 (sHR = 1.87; 95% CI 1.20; 2.93) were associated with a statistically significant higher mortality while seasonal influenza was not (sHR = 0.93; 95% CI 0.65; 1.31), when compared to RSV. Despite occurring in more severe patients, RSV and seasonal influenza group appear to be associated with a more favorable outcome than COVID-19 and H1N1 groups.

Keywords: ARDS; CARV; Influenza; RSV; SARS COV 2.

 
Back
Top Bottom